相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fc glycans of therapeutic antibodies as critical quality attributes
Dietmar Reusch et al.
GLYCOBIOLOGY (2015)
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
Ronnie Aronson et al.
DIABETES CARE (2014)
IgG1 Thioether Bond Formation in Vivo
Qingchun Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
With or Without Sugar? (A)glycosylation of Therapeutic Antibodies
Dmitrij Hristodorov et al.
MOLECULAR BIOTECHNOLOGY (2013)
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Maya K. Leabman et al.
MABS (2013)
Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress
Takahiko Ito et al.
PROTEIN SCIENCE (2013)
Unexpected Hematologic Effects of Biotherapeutics in Nonclinical Species and in Humans
Nancy E. Everds et al.
TOXICOLOGIC PATHOLOGY (2013)
Different Adaptations of IgG Effector Function in Human and Nonhuman Primates and Implications for Therapeutic Antibody Treatment
Max Warncke et al.
JOURNAL OF IMMUNOLOGY (2012)
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
Sang Taek Jung et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Molecular and Functional Characterization of Cynomolgus Monkey IgG Subclasses
Frederick W. Jacobsen et al.
JOURNAL OF IMMUNOLOGY (2011)
Acid-Induced Aggregation of Human Monoclonal IgG1 and IgG2: Molecular Mechanism and the Effect of Solution Composition
Sanjay B. Hari et al.
BIOCHEMISTRY (2010)
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
B. Keymeulen et al.
DIABETOLOGIA (2010)
Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals
Takashi Ishihara et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
Tanja Schneider-Merck et al.
JOURNAL OF IMMUNOLOGY (2010)
Engineering host cell lines to reduce terminal sialylation of secreted antibodies
Michael F. Naso et al.
MABS (2010)
Recovery and purification process development for monoclonal antibody production
Hui F. Liu et al.
MABS (2010)
Development trends for human monoclonal antibody therapeutics
Aaron L. Nelson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Optimization of Fc-mediated effector functions of monoclonal antibodies
William R. Strohl
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Engineered Human Antibody Constant Domains with Increased Stability
Rui Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
Royston Jefferis
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Human IgG2 antibodies display disulfide-mediated structural isoforms
Jette Wypych et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural and functional characterization of disulfide isoforms of the human IgG2 subclass
Thomas M. Dillon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The antiinflammatory activity of IgG: the intravenous IgG paradox
Falk Nimmerjahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins
James N. Arnold et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms
Y Mimura et al.
MOLECULAR IMMUNOLOGY (2000)
Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc
EE Idusogie et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
